India’s upcoming semaglutide boom: A turning point for GLP‑1 drugs, pricing and patient access
With semaglutide’s Indian patent set to expire on March 20, 2026, domestic drugmakers are preparing to enter the GLP‑1 market,…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.